Increased expression of fatty-acid and calcium metabolism genes in failing human heart

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  García Rúa, Vanessa ^a   Otero, Manuel Francisco ^a   Lear, Pamela Virginia ^a   Rodríguez Penas, Diego ^a   Feijóo Bandín, Sandra ^a   Noguera Moreno, Teresa ^a   Calaza, Manuel ^a   Álvarez Barredo, María ^a   Mosquera Leal, Ana ^a   Parrington, John ^b   Brugada, Josep ^c   Portolés, Manuel ^d   Rivera, Miguel ^d   González Juanatey, José Ramón ^a   Lago, Francisca ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALCIUM; CD36 ANTIGEN; CELL PROTEIN; FATTY ACID; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; CALCIUM CHANNEL; HEAT SHOCK PROTEIN; PPARGC1A PROTEIN, HUMAN; PRIMER DNA; TPCN1 PROTEIN, HUMAN; TPCN2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CALCIUM METABOLISM; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID TRANSPORT; FEMALE; GENE EXPRESSION; HEART MUSCLE; HUMAN; IMMUNOBLOTTING; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CASE CONTROL STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART FAILURE; HEART VENTRICLE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANTIGENS, CD36; CALCIUM; CALCIUM CHANNELS; CASE-CONTROL STUDIES; DNA PRIMERS; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLES; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MYOCARDIUM; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS;

EID: 84862001699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037505     Document Type: Article

References (64)

1. Opie LH, Knuuti J, (2011) The Adrenergic-Fatty Acid Load in Heart Failure. JACC 54: 1637-1646.
2. Lionetti V, Stanley WC, Recchia FA, (2011) Modulating fatty acid oxidation in heart failure. Cardiovasc Res 90: 202-209.
3. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ, (2009) Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res 81: 420-428.
4. Glatz JF, Bonen A, Ouwens DM, Luiken JJ, (2006) Regulation of sarcolemmal transport of substrates in the healthy and diseased heart. Cardiovasc Drugs Ther 20: 471-476.
5. Schwenk RW, Luiken JJ, Bonen A, Glatz JF, (2008) Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res 79: 249-258.
6. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD, (2011) Targeting fatty acid and carbohydrate oxidation - a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 1813 1333-1350 pp. 1333-1350.
7. Heather LC, Clarke K, (2011) Metabolism, hypoxia and the diabetic heart. J Mol Cell Cardiol 50: 598-605.
8. Glatz JF, Bonen A, Luiken JJ, (2002) Exercise and insulin increase muscle fatty acid uptake by recruiting putative fatty acid transporters to the sarcolemma. Curr Opin Clin Nutr Metab Care 5: 365-370.
9. Nakata T, Hashimoto A, Haseb M, Tsuchihashia K, Shimamoto K, (2003) Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 99: 96-104.
10. Pelsers MM, Hermensb WT, Glatz JF, (2005) Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352: 15-35.
11. Son NH, Yu S, Tuinei J, Arai K, Hamai H, et al. (2010) PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation. J Clin Invest 120: 3443-3454.
12. Desvergne B, Wahli W, (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688.
13. Duncan JG, (2011) Peroxisome proliferator activated receptor-alpha (PPARa) and PPAR gamma coactivator-1alpha (PGC-1a) regulation of cardiac metabolism in diabetes. Pediatr Cardiol 32: 323-328.
14. Karbowska J, Kochan Z, Smolenski RT, (2003) Peroxisome proliferator-activated receptor a is downregulated in the failing human heart. Cell Mol Biol Lett 8: 49-53.
15. Schupp M, Kintscher U, Fielitz J, Thomas J, Pregla R, et al. (2006) Cardiac PPARa expression in patients with dilated cardiomyopathy. Eur J Heart Fail 8: 290-294.
16. Goikoetxea MJ, Beaumont J, González A, López B, Querejeta R, et al. (2006) Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. Cardiovasc Res 69: 899-907.
17. Holloway GP, Snook LA, Harris RJ, Glatz JF, Luiken JJ, et al. (2011) In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation. J Physiol 589.1: 169-180.
18. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, et al. (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104: 2923-2931.
19. Sharma V, Dhillon P, Parsons H, Allard MF, McNeill JH, (2009) Metoprolol represses PGC1α-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart. Eur J Pharmacol 607: 156-166.
20. Sack MN, Rader TA, Park S, Bastin J, McCune SA, et al. (1996) Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94: 2837-2842.
21. Rennison JH, McElfresh TA, Okere IC, Patel HV, Foster AB, et al. (2008) Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 79: 331-340.
22. Sihag S, Lib AY, Crescib S, Sucharovc CC, Lehman JJ, (2009) PGC-1α and ERRα target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol 46: 201-212.
23. Finck BN, Kelly DP, (2007) Peroxisome proliferator-activated receptor G coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115: 2540-2548.
24. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K, (2004) Uncoupling proteins in the human heart. Lancet 364: 1786-1788.
25. Wu P, Peters JM, Harris RA, (2001) Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor α. Biochem Biophys Res Commun 287: 391-396.
26. Huang B, Wu P, Bowker-Kinley MM, Harris RA, (2002) Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-α ligands, glucocorticoids, and insulin. Diabetes 51: 276-283.
27. Murray AJ, Panagia M, Hauton D, Gibbons GF, Clarke K, (2005) Plasma free fatty acids and peroxisome proliferator-activated receptor-α in the control of myocardial uncoupling protein levels. Diabetes 54: 3496-3502.
28. Stanley WC, Recchia FA, Lopaschuk GD, (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129.
29. Turer AT, Malloy CR, Newgard CB, Podgoreanu MV, (2010) Energetics and metabolism in the failing heart: important but poorly understood. Curr Opin Clin Nutr Metab Care 13: 458-465.
30. Fu S, Yang L, Li P, Hofmann O, Dicker L, et al. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473: 528-531.
31. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, et al. (1995) Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 95: 888-894.
32. 2+ channels in endoplasmic reticulum stress and β-cell death. Diabetes 58: 422-432.
33. Bayer JD, Narayan SM, Lalani GG, Trayanova NA, (2009) Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling. Heart Rhythm 7: 1093-1101.
34. Minamino T, Komuro I, Kitakaze M, (2010) Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res 107: 1071-1082.
35. Fu HY, Okada K-I, Liao Y, Tsukamoto O, Isomura T, et al. (2010) Ablation of C/EBP homologous protein attenuates endoplasmic reticulum mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation 122: 361-369.
36. 2+ transients and arrhythmias associated with cardiac hypertrophy. Proc Natl Acad Sci USA 106: 11406-11411.
37. 2+ stores in the heart. J Biol Chem 282: 15302-15311.
38. Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, et al. (2009) NAADP mobilises calcium from acidic organelles through two-pore channels. Nature 459: 596-601.
39. 2+ release channels. Pflugers Arch 458: 869-876.
40. Cortés R, Roselló-Lletí E, Rivera M, Martínez-Dolz L, Azorín I, et al. (2009) The role of the nuclear lamins in the pathogenesis of heart failure in patients undergoing cardiac transplantation. Transplantation Proceedings 41: 2227-2230.
41. Cortés R, Roselló-Lletí E, Rivera M, Martínez-Dolz L, Salvador A, et al. (2010) Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes. Cardiovasc Res 85: 464-472.
42. 2+-release from lysosomal stores. Pflugers Arch 458: 891-899.
43. Hooper R, Churamani D, Brailoiu E, Taylor CW, Patel S, (2011) Membrane topology of NAADP-sensitive two-pore channels and their regulation by N-linked glycosylation. J Biol Chem 286: 9141-9149.
44. R Development Core Team (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org. Accessed December 2011.
45. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del Monte F, et al. (2010) Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 106: 1541-1548.
46. Sebastiani M, Giordano C, Nediani C, Travaglini C, Boschi E, et al. (2007) Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol 50: 1362-1369.
47. Garnier A, Zoll J, Fortin D, N'Guessan B, Lefebvre F, et al. (2009) Control by Circulating Factors of Mitochondrial Function and Transcription Cascade in Heart Failure: A Role for Endothelin-1 and Angiotensin II. Circ Heart Fail 2: 342-350.
48. Mettauer B, Zoll J, Sánchez H, Lampert E, Ribera F, et al. (2001) Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 38: 947-954.
49. Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, et al. (2010) Analysis of metabolic remodelling in compensated left ventricular hypertrophy and heart failure. Circ Heart Fail 3: 420-430.
50. Garnier A, Fortin D, Deloménie C, Momken I, Veksler V, et al. (2003) Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551.2: 491-501.
51. Roselló-Lletí E, Rivera M, Cortés R, Azorín I, Sirera R, et al. (2012) Influence of heart failure on nucleolar organization and protein expression in human hearts. Biochem Biophys Res Commun 418: 222-228.
52. Cortés R, Rivera M, Roselló-Lletí E, Martínez-Dolz L, Almenar L, et al. (2012) Differences in MEF2 and NFAT Transcriptional Pathways According to Human Heart Failure Aetiology. PLoS One 7: e30915.
53. Pohl J, Fitscher BA, Ring A, Ihl-Vahl R, Strasser RH, et al. (2000) Fatty acid transporters in plasma membranes of cardiomyocytes in patients with dilated cardiomyopathy. Eur J Med Res 5: 438-442.
54. Uray IP, Connelly JH, Frazier H, Taegtmeyer H, Davies PJA, (2003) Mechanical unloading increases caveolin expression in the failing human heart. Cardiovasc Res 59: 57-66.
55. Yang J, Sambandam N, Han X, Gross RW, Courtois M, et al. (2007) CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 100: 1208-1217.
56. Teboul L, Febbraio M, Gaillard D, Amri EZ, Silverstein R, et al. (2001) Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation. Biochem J 360: 305-312.
57. Sato O, Kuriki C, Fukui Y, Motojima K, (2002) Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J Biol Chem 277: 15703-15711.
58. Duncan JG, Bharadwaj KG, Fong JL, (2010) Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-α transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-α activators. Circulation 121: 426-435.
59. Holloway GP, Bonen A, Spriet LL, (2009) Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals. Am J Clin Nutr 89: 455S-462S.
60. Heather LC, Howell NJ, Emmanuel Y, (2011) Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One 6: e26326.
61. 2+ handling in heart failure. J Clin Invest 115: 556-564.
62. 2+ Regulatory Protein and Potential Therapeutic Drug Target. Curr Drug Targets 12: 709-723.
63. Galione A, (2011) NAADP receptors. Cold Spring Harb Perspect Biol 3: a0040362011.
64. Crossman DJ, Ruygrok PR, Soeller C, Cannell MB, (2011) Changes in the organization of excitation-contraction coupling structures in failing human heart. PLoS One 6: e17901.